Sürekli Renal Replasman Tedavisinin Komplikasyonları

Abidi SM, Khan A, Fried LF, Chelluri L, Bowles S, Greenberg A. Factors influencing function of temporary dialysis catheters. Clin Nephrol 2000;53(3):199-205.

Akhoundi A, Singh B, Vela M, et al. Incidence of adverse events during continuous renal replacement therapy. Blood Purif 2015;39(4):333-9.

A.Vijayan. Vasculer acccess for continuous renal replacement therapy. Semin Dial 2009;22(2):133-6.

Berger MM, Shenkin A. Update on clinical micronutrient supplementation studies in the critically ill. Curr Opin Clin Nutr Metab Care 2006;9(6):711-6.

Berger MM, Shenkin A, Revelly JP, et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004;80(2):410-6

Bollmann MD, Revelly JP, Tappy L, et al.Effect of bicarbonate and lactate buffer on glucose and lactate metabolism during hemodiafiltration in patients with multiple organ failure. Intensive Care Med 2004;30(6):1103-10.

Cano NJ, Aparicio M, Brunori G,et al. ESPEN Guidelines on Parenteral Nutrition: adult renal failure. Clin Nutr 2009;28(4):401-14.

Finkel KW, Podoll AS. Complications of continuous renal replacement therapy. Semin Dial 2009;22(2):155-9.

Gainza FJ, Quintanilla N, Pijoan JI, Delgado S, Urbizu JM, Lampreabe I. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis. J Nephrol 2006;19(5):648-55.

Gibney N, Cerda J, Davenport A, et al. Volume management by renal replacement therapy in acute kidney injury. Int J Artif Organs 2008;31(2):145-55.

Hofmann JN, Vollmar B, Laschke MW, et al. Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. Thromb Haemost 2002;88(2):242-52.

Honore PM, De Waele E, Jacobs R, et al. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif 2013;35(4):279–84.

Jones S. Heat loss and continuous renal replacement therapy. AACN Clin Issues 2004;15(2):223-30.

Jung SY, Kim H, Park S, et al. Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy. Medicine (Baltimore) 2016;95(36):e4542.

Karakitsos D, Labropoulos N, De Groot E, et al. Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care 2006;10(6):162-9.

KDIGO AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012;(suppl 2):1-138.

Khadzhynov D, Schelter C, Lieker I, et al. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care 2014;29(2):265-71.

Leverve XM, Cano NJ. Nutritional management in acute illness and acute kidney insufficiency. Contrib Nephrol 2007;156:112-8.

Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 2006;1:43-51.

Lim C, Tan HK, Kaushik M. Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events. Clin Kidney J 2017;10(3):341-7.

Link A, Girndt M, Selejan S, Mathes A, Böhm M, Rensing H. Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med 2009;37(1):105-10.

Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infec- tion with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med 2012;40(8):2479-85.

Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionised calcium ratio during continuous venovenous haemodialysis with regional citrate anticoagulation. Crit Care Med 2001;29(4):748-52.

Merrer J, De Joughe B, Golliot F, et al. Complications of femoral and subclavian venous catheterisation in critically ill patients. JAMA 2001;286(6):700-7.

Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E. Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol 2014;9(12):2173-88.

Morgera S, Haase M, Rückert M, et al. Regional citrate anticoagulation in continuous hemodialysis– acid-base and electrolyte balance at an increased dose of dialysis. Nephron Clin Pract 2005;101(4):211-9.

Oliver MJ. Acute dialysis catheters. Semin Dial 2001;14(6):432-5.

Parienti JJ, Thirion M, Mégarbane B, et al. Members of the Cathedia Study Group: Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: A randomized controlled trial. JAMA 2008;299(20):2413-22.

Polderman KH, Girbes AJ. Central venous catheter use. Part 1: mechanical complications. Intensive Care Med 2002;28(1):1-17.

Rokyta R Jr, Matejovic M, Krouzecky A, Opatrny K Jr, Ruzicka J, Novak I.Effects of continuous venovenous haemofiltration induced cooling on global haemodynamics, splanchnic oxygen and energy balance in critically ill patients. Nephrol Dial Transplant 2004;19(3):623-30.

Schultheiss C, Saugel B, Phillip V, et al. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care 2012;16(4):162.

Selleng K, Warkentin TE, Greinacher A.Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 2007;35(4):1165-76.

Shingarev R, Wille K, Tolwani A. Management of complications in renal replacement therapy. Semin Dial 2011;24(2):164-8.

Shor R, Halabe A, Rishver S, et al. Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci 2006;36(1):67-72.

Stoves J, Goode NP, Visvanathan R ,et al. The bradykinin response and early hypotension at the introduction of continuous renal replacement therapy in the intensive care unit. Artif Organs 2002;25(12):1009-13.

Tanguay TA, Jensen L, Johnston C. Predicting episodes of hypotension by continuous blood volume monitoring among critically ill patients in acute renal failure on intermittent hemodialysis. Dynamics 2007;18(3):19-24.

Tolwani A. Continuous renal replacement therapy for acute kidney injury. N Engl J Med 2012;367(26):250-14.

Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med 2004;30(8):1662-5.

Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294(7):813-8.

Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001;286(15):1869-78.

Wooley JA, Btaiche IF, Good KL. Metabolic and nutritional aspects of acute renal failure in critically ill patients requiring continuous renal replacement therapy. Nutr Clin Pract 2005;20(2):176-91.

Yang Y, Zhang P, Cui Y, et al. Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care 2013;17(5):205.

Zhongping H, Jeffrey JL, Claudo R, et al. Basic principles of solute transport. In: John AK, Bellomo R, Claudo R, editors. Continuous renal replacement therapy. 1st edition. Oxford: Oxford University Press; 2010:25-33.

Abidi SM, Khan A, Fried LF, Chelluri L, Bowles S, Greenberg A. Factors influencing function of temporary dialysis catheters. Clin Nephrol 2000;53(3):199-205.

Akhoundi A, Singh B, Vela M, et al. Incidence of adverse events during continuous renal replacement therapy. Blood Purif 2015;39(4):333-9.

A.Vijayan. Vasculer acccess for continuous renal replacement therapy. Semin Dial 2009;22(2):133-6.

Berger MM, Shenkin A. Update on clinical micronutrient supplementation studies in the critically ill. Curr Opin Clin Nutr Metab Care 2006;9(6):711-6.

Berger MM, Shenkin A, Revelly JP, et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004;80(2):410-6

Bollmann MD, Revelly JP, Tappy L, et al.Effect of bicarbonate and lactate buffer on glucose and lactate metabolism during hemodiafiltration in patients with multiple organ failure. Intensive Care Med 2004;30(6):1103-10.

Cano NJ, Aparicio M, Brunori G,et al. ESPEN Guidelines on Parenteral Nutrition: adult renal failure. Clin Nutr 2009;28(4):401-14.

Finkel KW, Podoll AS. Complications of continuous renal replacement therapy. Semin Dial 2009;22(2):155-9.

Gainza FJ, Quintanilla N, Pijoan JI, Delgado S, Urbizu JM, Lampreabe I. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis. J Nephrol 2006;19(5):648-55.

Gibney N, Cerda J, Davenport A, et al. Volume management by renal replacement therapy in acute kidney injury. Int J Artif Organs 2008;31(2):145-55.

Hofmann JN, Vollmar B, Laschke MW, et al. Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. Thromb Haemost 2002;88(2):242-52.

Honore PM, De Waele E, Jacobs R, et al. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif 2013;35(4):279–84.

Jones S. Heat loss and continuous renal replacement therapy. AACN Clin Issues 2004;15(2):223-30.

Jung SY, Kim H, Park S, et al. Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy. Medicine (Baltimore) 2016;95(36):e4542.

Karakitsos D, Labropoulos N, De Groot E, et al. Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care 2006;10(6):162-9.

KDIGO AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012;(suppl 2):1-138.

Khadzhynov D, Schelter C, Lieker I, et al. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care 2014;29(2):265-71.

Leverve XM, Cano NJ. Nutritional management in acute illness and acute kidney insufficiency. Contrib Nephrol 2007;156:112-8.

Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 2006;1:43-51.

Lim C, Tan HK, Kaushik M. Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events. Clin Kidney J 2017;10(3):341-7.

Link A, Girndt M, Selejan S, Mathes A, Böhm M, Rensing H. Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med 2009;37(1):105-10.

Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infec- tion with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med 2012;40(8):2479-85.

Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionised calcium ratio during continuous venovenous haemodialysis with regional citrate anticoagulation. Crit Care Med 2001;29(4):748-52.

Merrer J, De Joughe B, Golliot F, et al. Complications of femoral and subclavian venous catheterisation in critically ill patients. JAMA 2001;286(6):700-7.

Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E. Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol 2014;9(12):2173-88.

Morgera S, Haase M, Rückert M, et al. Regional citrate anticoagulation in continuous hemodialysis– acid-base and electrolyte balance at an increased dose of dialysis. Nephron Clin Pract 2005;101(4):211-9.

Oliver MJ. Acute dialysis catheters. Semin Dial 2001;14(6):432-5.

Parienti JJ, Thirion M, Mégarbane B, et al. Members of the Cathedia Study Group: Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: A randomized controlled trial. JAMA 2008;299(20):2413-22.

Polderman KH, Girbes AJ. Central venous catheter use. Part 1: mechanical complications. Intensive Care Med 2002;28(1):1-17.

Rokyta R Jr, Matejovic M, Krouzecky A, Opatrny K Jr, Ruzicka J, Novak I.Effects of continuous venovenous haemofiltration induced cooling on global haemodynamics, splanchnic oxygen and energy balance in critically ill patients. Nephrol Dial Transplant 2004;19(3):623-30.

Schultheiss C, Saugel B, Phillip V, et al. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care 2012;16(4):162.

Selleng K, Warkentin TE, Greinacher A.Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 2007;35(4):1165-76.

Shingarev R, Wille K, Tolwani A. Management of complications in renal replacement therapy. Semin Dial 2011;24(2):164-8.

Shor R, Halabe A, Rishver S, et al. Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci 2006;36(1):67-72.

Stoves J, Goode NP, Visvanathan R ,et al. The bradykinin response and early hypotension at the introduction of continuous renal replacement therapy in the intensive care unit. Artif Organs 2002;25(12):1009-13.

Tanguay TA, Jensen L, Johnston C. Predicting episodes of hypotension by continuous blood volume monitoring among critically ill patients in acute renal failure on intermittent hemodialysis. Dynamics 2007;18(3):19-24.

Tolwani A. Continuous renal replacement therapy for acute kidney injury. N Engl J Med 2012;367(26):250-14.

Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med 2004;30(8):1662-5.

Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294(7):813-8.

Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001;286(15):1869-78.

Wooley JA, Btaiche IF, Good KL. Metabolic and nutritional aspects of acute renal failure in critically ill patients requiring continuous renal replacement therapy. Nutr Clin Pract 2005;20(2):176-91.

Yang Y, Zhang P, Cui Y, et al. Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care 2013;17(5):205.

Zhongping H, Jeffrey JL, Claudo R, et al. Basic principles of solute transport. In: John AK, Bellomo R, Claudo R, editors. Continuous renal replacement therapy. 1st edition. Oxford: Oxford University Press; 2010:25-33.